NEWARK, Del, March 10, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Post-Traumatic Stress Disorder (PTSD) Treatment Market is expected to grow at a value of 5% CAGR, according to Future Market Insights. By the year 2033, the global market for post-traumatic stress disorder (PTSD) treatment is expected to rise up to a market valuation of US$ 27.37 billion. Growth of the market can be attributed to increasing prevalence of PTSD worldwide.
According to the National Center for PTSD, approximately 7-8% of the US population will experience PTSD at some point in their lives, with higher rates among military veterans and individuals who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been identified as a potential driver of PTSD, with healthcare workers, frontline responders, and individuals who have been directly affected by the virus at increased risk.
Get a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16801
There is also a growing focus on the use of digital therapeutics and other non-pharmacological interventions for the treatment of PTSD. One example is the use of virtual reality exposure therapy (VRET), which has shown promising results in reducing PTSD symptoms by allowing individuals to confront their trauma in a safe and controlled environment. Several companies, including Limbix and Psious, are developing VRET platforms for the treatment of PTSD and other mental health conditions.
Key Takeaways from the Market Study
- The post-traumatic stress disorder (PTSD) treatment market is expected to grow at a value of 5% CAGR in the forecast period 2023 to 2033.
- By drug class, antidepressants are expected to hold 41% of the market share in 2023 for post-traumatic stress disorder (PTSD) treatment market.
- North America is expected to possess 43% market share for post-traumatic stress disorder (PTSD) treatment market in 2023.
- Europe post-traumatic stress disorder (PTSD) treatment market size is expected to possess 42% market share in 2023.
“As the prevalence of PTSD continues to rise, the need for effective and accessible treatments will only become more pressing. While there is still much work to be done, the growing focus on PTSD treatment is a positive step forward in improving the lives of individuals affected by this debilitating condition,” states an FMI analyst.
Contact our Market Research Specialist: https://www.futuremarketinsights.com/ask-question/rep-gb-16801
Competitive Landscape
Key players in the post-traumatic stress disorder (PTSD) treatment market are: Jazz Pharmaceuticals, Aptinyx, Otsuka Pharmaceutical Development & Commercialization, Inc., Bionomics Limited, Merck KGaA, Pfizer Inc., Aurobindo Pharma Limited, GlaxoSmithKline plc, Viatris Inc., Jubilant Pharmova
- Otsuka has also partnered with the U.S. Department of Veterans Affairs (VA) to conduct a clinical trial of a medication called samidorphan (ALKS 5461) for the treatment of PTSD. Samidorphan is an opioid system modulator that is being investigated for its ability to reduce symptoms of PTSD, including anxiety, depression, and hyperarousal.
- Bionomics Limited is a biopharmaceutical company that has developed a medication called BNC210, which is being investigated as a potential treatment for PTSD (Post-Traumatic Stress Disorder). BNC210 is a small molecule drug that acts as a negative allosteric modulator of the α7 nicotinic acetylcholine receptor (α7 nAChR), which is thought to play a role in the development and maintenance of PTSD symptoms.
Key Segments Profiled in the Post-Traumatic Stress Disorder (PTSD) Treatment Industry Survey
By Drug Class:
- Antidepressants
- Anti-anxiety Drugs
- Antipsychotics
- Other Drug Classes
By Distribution Channel:
- Retail Pharmacies
- Online Pharmacies
Buy This Report: https://www.futuremarketinsights.com/checkout/16801
Table of Content
1. Executive Summary | Post-Traumatic Stress Disorder (PTSD) Treatment Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
Complete TOC with Report Preview: https://www.futuremarketinsights.com/reports/post-traumatic-stress-disorder-treatment-market
Have a Look at Related Research Reports of Healthcare Domain:
Stethoscope Market Size - The global stethoscope market should expand and hit US$ 1056.0 million by the end of 2033, up from US$ 612.9 million in 2023. It is envisioned to progress at a CAGR of 5.6% between 2023 and 2033, creating an absolute dollar opportunity of US$ 38.4 million.
Respiratory Pathogen Testing Kits Market Share - As per the latest market research conducted by FMI, the global respiratory pathogen testing kits market is expected to record a CAGR of 5.7% from 2023 to 2033. In 2023, the market size is projected to reach a valuation of US$ 4,083.1 million. By 2033, the valuation is expected to be worth US$ 7,136.8 million.
Upper Limb Prosthetics Market Growth - The global sales of upper limb prosthetics are likely to stand at around US$ 398 million in 2023. As per detailed industry analysis, the global upper limb prosthetics market is projected to increase at a CAGR of 4.1% and reach a valuation of US$ 624.9 million by the year 2033.
Self-testing Market Forecast - The FMI anticipates that the self-testing market is anticipated to capture a valuation of US$ 7.89 billion in 2023. The market is projected to rise to US$ 13.6 billion by 2033. The market is securing a CAGR of 5.6% during the forecast period.
Localized Temperature Therapy Products Market Demand - The global localized temperature therapy products market is set to record a market value of US$ 1,752.9 million in 2023 pushing the market size to US$ 3,055.6 million in 2033. A CAGR of 5.7% indicates positive market growth over the forecast period.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S., and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedIn| Twitter| Blogs | YouTube
